PuraMed BioScience Inc. has appointed Patricia McMurtrie as president, chief operating officer and director.


PuraMed BioScience, Patricia McMurtrie, chief operating officer, president, over-the-counter medicines, health care products, LipiGesic M, natural migraine pain reliever, Russ Mitchell


































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

PuraMed BioScience names president, COO

June 4th, 2014

SCHOFIELD, Wis. – PuraMed BioScience Inc. has appointed Patricia McMurtrie as president, chief operating officer and director.

The developer and marketer of over-the-counter medicines and health care products, said Tuesday that McMurtrie is responsible for the oversight of day-to-day business functions as well as key product development and distribution functions.

"I'm pleased to welcome Patricia to the PuraMed team," stated Russ Mitchell, chairman and chief executive officer of PuraMed BioScience. "Patricia has an intimate knowledge of the company and our products. I believe that her presence will support and drive PuraMed's continued growth and prosperity as we move forward."

McMurtrie brings to PuraMed BioScience over 20 years of business experience in marketing and communications. As co-owner and marketing director for Envision Marketing & Design, LLC since 2001, she has extensive experience working with many clients from a variety of industries, PuraMed noted.

"I am excited to be part of the PuraMed BioScience team," McMurtrie commented. "I've seen LipiGesic M, a natural migraine pain reliever, make a difference in the lives of people in my personal circle. It is extremely rewarding to be a part of a company that can change people's lives for the better. I look forward to the development and distribution of additional products that are just as effective in the lives of others."

In addition to LipiGesic M, PuraMed BioScience plans to launch additional cannabinoid enhanced anti-inflammatory and anxiolytic products as it moves forward in the development of its CBD product line.

Advertisement